Novavax, Inc. (NASDAQ:NVAX) could surge as high as $17

5744

Novavax, Inc. (NASDAQ:NVAX) has a 1 Year Target Estimate of $8.74. The stock traded with the volume of 37.77 Million in the last trading session. Novavax, Inc. opened at $2.3 and closed at $2.26 by showing an increase of 3.98%. The Bid price in the last session was $2.39 x 1600 and the Ask price was $2.40 x 5100. (The ask price is what sellers are willing to take for it. If you are selling a stock, you are going to get the bid price, if you are buying a stock you are going to get the ask price. The difference (or spread) goes to the broker/specialist that handles the transaction).

Novavax, Inc. has the Market Capitalization of 636.57 Million. The Stock has its 52-week High of $9.23 and 52-Week Low of $1.16 and it touched its 52-week high on Dec 2, 2015 and 52-Week Low on Sep 16, 2016.

Novavax, Inc. reported its last Earnings on Aug 09 AMC where the company reported Actual EPS of $-0.29/Share whereas, the Analyst Estimated EPS was $-0.25/share. The difference between Actual EPS and Estimated EPS was $-0.04/share. This represented an Earnings Surprise of -16%. The company will report its next earnings on Nov 7 – Nov 11 (Est.).

Some analyst provided their insight on Growth Estimates; Novavax, Inc. has the Current Quarter Earnings Growth rate of -116.7%. The Next Quarter growth is expected to be 13.8%. In the past 5 years, the stock has earnings growth rate of 0% per annum while the Upcoming 5 year’s earnings growth rate is expected to be 0% per annum.

7 number of analysts also provided their insight on Novavax, Inc., where the Average Price Target for the stock is $8.74. They also projected Low Price Target as $1 while High Price Target is set at $17.

A number of analysts rated the stock as well: 5 analysts believe that the stock is a STRONG BUY while 3 reported it as Buy.1 analysts assigned a HOLD rating, 0 said it’s UNDERPERFORM and 0 say that this stock is a SELL.

Novavax, Inc. annual Divided is 0 while it’s Dividend Yield is 0%. The stock has its Price to Earnings (P/E) ratio of 0 and Forward Price to Earnings ratio of 0. The company has its Price to Sales (P/S) ratio of 33.37 where Price to Book (P/B) ratio of 5.73, Price to Cash Per share (P/C) of 1.74 and Price to Free Cash Flow (P/FCF) has a value of 0.

The company has its Return on Assets (ROA) of -56.3 Percent. Return on Equity (ROE) stands at -112.4% and Return on Investment (ROI) displays a value of -53.6%.

The stock is currently trading at Distance from 20-Day simple moving Average of -59.11% whereas, Distance from 50-Day Simple moving average is -64.87 Percent and Distance from 200-Day Simple Moving Average of -61.76 percent.

A look at performance overview of Novavax, Inc. depicts that Performance (Week) is 57.72 percent while Performance Month is -65.79%. Quarterly performance shows a value of -62.52% and Half Year Performance value stands at -54.89%. Yearly performance of the stock has the value of -72.77 percent. Novavax, Inc. has its YTD performance of -71.99 Percent. (YTD performance is the most important factor to consider; if YTD is negative, the stock is declining; if the YTD Performance value is Positive the stock is surging).

Insider Trades:

Many Insiders have done trades inside the company. The latest trade was made on 20 Sep 2016 where Officer Glenn (Gregory M) did a transaction type “Buy” in which 1000 shares were traded at a price of $1.65. Another insider trade includes Director Douglas (Richard H) who also initiated a transaction in which 100000 shares were traded on 20 Sep 2016 as “Buy”. On 20 Sep 2016 Director McManus (Michael A Jr) traded 30000 shares as “Buy” at $1.61. Chief Financial Officer Phillips (Barclay A) Buy 422 shares on 30 Jul 2016 at the price of $4.29.

Upgrades/Downgrades Report:

The latest Upgrades/Downgrades was done by Research firm Citigroup on 16-Sep-16 who Downgrade the stock from Buy to Neutral. Other firms have also Upgraded/Downgraded the stock. On 16-Sep-16, Wedbush took an action “Downgrade” from Outperform to Neutral. On 16-Sep-16, the stock was Downgrade to Neutral by Ladenburg Thalmann.

SHARE